AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a study published in the July issue of The Journal of Urology.

Sakina Mohammed Mota, Ph.D., from Avenda Health, and colleagues compared physicians' performance using AI versus standard-of-care methods for tumor delineation in a multireader, multicase study. Cases were interpreted by seven urologists and three radiologists from five institutions with two to 23 years of experience. Fifty prostatectomy cases eligible for focal therapy were retrospectively assessed by each reader. Readers defined cancer contours cognitively, delineating tumor boundaries manually to encapsulate all clinically significant disease. After four or more weeks, the same cases were contoured using AI software.

The researchers found that the balanced accuracy (mean of voxel-wise sensitivity and specificity) of AI-assisted cancer contours was superior to cognitively defined and hemigland contours (84.7 percent versus 67.2 and 75.9 percent, respectively). Cancer extent was systemically underestimated by cognitively defined cancer contours, with a negative margin rate of 1.6 percent compared with 72.8 percent for AI-assisted cancer contours.

"Overall, the use of AI in cancer treatment could lead to more effective and personalized care for patients, with treatments that are better tailored to their individual needs and more successful in fighting the disease,” coauthor Wayne G. Brisbane, M.D., from the David Geffen School of Medicine in Los Angeles, said in a statement.

Several authors disclosed ties to Avenda Health.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords